Undetectable to the Naked eye
Almost all eye related diseases are difficult to detect
because symptoms do not show until the disease has progressed for about 80%.
Late stage detection of retinal diseases presents serious risks because eyesight becomes irreversible and incurable.
ELI, a wearable fundus camera possesses an auto-shot feature which
removes the need for manually adjusting the camera to focus on the retina.
This removes the need for patients to undergo taking several photos with flashes.
ELI is a cost-effective device for preliminary screening as well as consistent management.
Detailed imaging of the retina and fundus allows for a more comprehensive analysis of eye-related disease as well as vascular diseases.
Recent advancements in the field of science has opened doors to numerous technologies that can be applied to the medical industry.
We have embraced this change to advance the field of ophthalmology with next-generation technology.
Auto-shot is a feature that allows for auto-focusing capability (device provides focus-assist to remove the need for multiple pictures) and automatically analyzes fundus imaging based on big data.
Retinal imaging takes place without the aid of mydriatic agents which eliminates the chance of side-effects.
Development of our unified management system for diagnosing blindness disease will provide a solution to increase medical accessibility drastically leading to consistent and effective prevention of blindness diseases.
Retinal imaging devices often require a darkroom and difficult to maintain due to size but ELI can be used anywhere which decreases the burden of additional costs.
Implementation of deep learning technology and AI recognition, our software is able to assist doctors
in diagnosing previously lost patients with a more thorough review of the condition of their eye and general health.